Stephen R. Brady
Chief Executive Officer at Tempest Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Tempest Therapeutics Inc., 3 years.
Tempest Therapeutics Inc.
Director · President and CEO
Chief executive roles
Tempest Therapeutics Inc.
· Chief Executive Officer
Until February 2026
· Former
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 3, 2024 | Tempest Therapeutics Inc. | Open-market purchase | +35,000 | $2.11 | $73,850 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.